Actarit

CAS No. 18699-02-0

Actarit( MS-932 | NSC 170317 )

Catalog No. M12889 CAS No. 18699-02-0

Actarit is an anti-inflammatory drug developed in Japan for use in rheumatoid arthritis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG 29 In Stock
500MG 45 In Stock
1G 65 In Stock

Biological Information

  • Product Name
    Actarit
  • Note
    Research use only, not for human use.
  • Brief Description
    Actarit is an anti-inflammatory drug developed in Japan for use in rheumatoid arthritis.
  • Description
    Actarit is an anti-inflammatory drug developed in Japan for use in rheumatoid arthritis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MS-932 | NSC 170317
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    18699-02-0
  • Formula Weight
    193.2
  • Molecular Formula
    C10H11NO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C(O)CC1=CC=C(NC(C)=O)C=C1
  • Chemical Name
    2-(4-acetamidophenyl)acetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Canudas N, et al. Arzneimittelforschung. 2008;58(4):182-7.
molnova catalog
related products
  • MPEP hydrochloride

    MPEP hydrochloride is an effective and highly specific non-competitive antagonist at the mGlu5 receptor subtype (IC50: 36 nM).

  • Neuropeptide W-30 (h...

    Neuropeptide W-30 (human) is an important stress mediator in the central nervous system that modulates the hypothalamus-pituitary-adrenal (HPA) axis and sympathetic outflow. Neuropeptide W-30 (human) is an endogenous ligand for the two structurally related orphan G-protein-coupled receptors (GPCRs) GPR7 and GPR8. Neuropeptide W-30 (human)activates and binds to both GPR7 and GPR8 at similar effective doses.

  • LtaS-IN-1

    LtaS-IN-1 is an effective inhibitor of Lipoteichoic acid synthesis in multidrug-resistant (MDR) E. faecium and by altering the cell wall morphology.